|
ZC3H8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.88178419700125E-16 |
| Normal-vs-Stage2 |
2.18800000006958E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.181020E-01 |
| Stage1-vs-Stage3 |
6.295700E-02 |
| Stage1-vs-Stage4 |
8.401100E-03 |
| Stage2-vs-Stage3 |
4.123800E-03 |
| Stage2-vs-Stage4 |
1.701100E-03 |
| Stage3-vs-Stage4 |
4.671400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
8.82560002857247E-09 |
| Normal-vs-Asian |
6.0981220073586E-12 |
| Caucasian-vs-AfricanAmerican |
9.288800E-01 |
| Caucasian-vs-Asian |
8.480400E-01 |
| AfricanAmerican-vs-Asian |
8.374000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
5.571400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.31870086967001E-11 |
| Normal-vs-Age(81-100Yrs) |
3.93870000003904E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.771400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.469400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.014800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.500400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.017200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.771600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.783500E-03 |
| Classical-VS-Follicular |
1.788330E-04 |
| Classical-VS-Other |
7.790400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
4.79969999966912E-07 |
| Tall-VS-Other |
3.505800E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
1.690580E-01 |
| Follicular-VS-Normal |
1.78090999999325E-05 |
| Other-VS-Normal |
7.96830000000526E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.105427357601E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.49490000000008E-05 |
|
|
